A detailed history of Geode Capital Management, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,114,778 shares of JAZZ stock, worth $137 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,114,778
Previous 1,114,861 0.01%
Holding current value
$137 Million
Previous $119 Million 4.42%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.57 - $116.37 $8,347 - $9,658
-83 Reduced 0.01%
1,114,778 $124 Million
Q2 2024

Aug 09, 2024

BUY
$103.94 - $118.98 $784,850 - $898,417
7,551 Added 0.68%
1,114,861 $119 Million
Q1 2024

May 13, 2024

BUY
$115.19 - $132.77 $6.67 Million - $7.69 Million
57,922 Added 5.52%
1,107,310 $133 Million
Q4 2023

Feb 13, 2024

BUY
$114.26 - $136.0 $4.19 Million - $4.98 Million
36,641 Added 3.62%
1,049,388 $129 Million
Q3 2023

Nov 13, 2023

BUY
$122.0 - $145.31 $1.79 Million - $2.13 Million
14,680 Added 1.47%
1,012,747 $131 Million
Q2 2023

Aug 11, 2023

BUY
$122.5 - $147.16 $5.43 Million - $6.52 Million
44,286 Added 4.64%
998,067 $124 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $2.3 Million - $2.75 Million
17,166 Added 1.83%
953,781 $140 Million
Q4 2022

Feb 13, 2023

BUY
$129.72 - $159.85 $7.96 Million - $9.81 Million
61,364 Added 7.01%
936,615 $149 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $1.93 Million - $2.46 Million
-15,276 Reduced 1.72%
875,251 $117 Million
Q2 2022

Aug 12, 2022

SELL
$141.59 - $168.66 $251,039 - $299,034
-1,773 Reduced 0.2%
890,527 $139 Million
Q1 2022

May 13, 2022

SELL
$129.64 - $160.7 $10.8 Million - $13.4 Million
-83,574 Reduced 8.56%
892,300 $139 Million
Q4 2021

Feb 11, 2022

BUY
$119.87 - $145.67 $6.95 Million - $8.45 Million
57,988 Added 6.32%
975,874 $124 Million
Q3 2021

Nov 12, 2021

SELL
$128.64 - $184.79 $10.4 Million - $14.9 Million
-80,768 Reduced 8.09%
917,886 $119 Million
Q2 2021

Aug 13, 2021

BUY
$160.2 - $186.42 $14.2 Million - $16.5 Million
88,386 Added 9.71%
998,654 $177 Million
Q1 2021

May 12, 2021

BUY
$150.19 - $173.5 $20.7 Million - $23.9 Million
137,574 Added 17.8%
910,268 $149 Million
Q4 2020

Feb 12, 2021

SELL
$140.71 - $165.05 $8.49 Million - $9.96 Million
-60,345 Reduced 7.24%
772,694 $127 Million
Q3 2020

Nov 13, 2020

SELL
$105.46 - $144.13 $2.89 Million - $3.94 Million
-27,368 Reduced 3.18%
833,039 $119 Million
Q2 2020

Aug 13, 2020

SELL
$95.68 - $121.88 $589,867 - $751,390
-6,165 Reduced 0.71%
860,407 $94.9 Million
Q1 2020

May 14, 2020

BUY
$87.74 - $152.74 $1 Million - $1.75 Million
11,431 Added 1.34%
866,572 $86.4 Million
Q4 2019

Feb 13, 2020

BUY
$117.65 - $153.73 $7.8 Million - $10.2 Million
66,319 Added 8.41%
855,141 $128 Million
Q3 2019

Nov 12, 2019

BUY
$125.18 - $143.24 $235,088 - $269,004
1,878 Added 0.24%
788,822 $101 Million
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $8.96 Million - $10.3 Million
71,350 Added 9.97%
786,944 $112 Million
Q1 2019

May 14, 2019

BUY
$121.81 - $142.95 $10.2 Million - $11.9 Million
83,564 Added 13.22%
715,594 $102 Million
Q4 2018

Feb 13, 2019

BUY
$115.94 - $166.74 $7.15 Million - $10.3 Million
61,649 Added 10.81%
632,030 $78.3 Million
Q3 2018

Nov 13, 2018

BUY
$161.01 - $180.57 $2.61 Million - $2.93 Million
16,232 Added 2.93%
570,381 $95.8 Million
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $16.2 Million - $20.3 Million
110,832 Added 25.0%
554,149 $95.4 Million
Q1 2018

May 15, 2018

BUY
$135.59 - $157.16 $3.14 Million - $3.64 Million
23,150 Added 5.51%
443,317 $66.9 Million
Q4 2017

Feb 13, 2018

BUY
$131.06 - $150.39 $1.35 Million - $1.55 Million
10,295 Added 2.51%
420,167 $56.5 Million
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $1.35 Million - $1.47 Million
9,442 Added 2.36%
409,872 $59.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
400,430
400,430 $62.2 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.